Trials / Recruiting
RecruitingNCT02099734
Germ Cell Tumor and Testicular Tumor DNA Registry
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (estimated)
- Sponsor
- Memorial Sloan Kettering Cancer Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This study is being done to create a registry to help us learn more about germ cell tumors (GCT) and other testicular tumors. The registry will include people with these tumors and also relatives and unrelated people without these tumors. This study will help us learn more about the prevention, diagnosis, treatment and outcome of these tumors. Studying relatives of patients and people unrelated to patients with GCT and other testicular tumors will help us understand why some people get these tumors and why some people don't.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Questionnaires | |
| OTHER | sample of blood or saliva | A sample of blood or saliva will be obtained for DNA extraction. Approximately 2-4 tubes of blood will be collected or one tablespoon of saliva. If a participant has already provided a DNA sample for another MSKCC IRB approved protocol, they may not need to provide an additional sample. |
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2028-01-01
- Completion
- 2028-01-01
- First posted
- 2014-03-31
- Last updated
- 2026-02-04
Locations
8 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02099734. Inclusion in this directory is not an endorsement.